A Randomised, Double Blind, Placebo Controlled Study to Evaluate the Micro-macroscopic Effects on Muscles, the Safety and Tolerability, and the Efficacy of Givinostat in Patients With Becker Muscular Dystrophy (BMD)
Phase of Trial: Phase II
Latest Information Update: 06 May 2018
At a glance
- Drugs Givinostat (Primary)
- Indications Duchenne muscular dystrophy
- Focus Therapeutic Use
- Sponsors Italfarmaco
- 15 Dec 2017 Status changed from not yet recruiting to recruiting.
- 04 Dec 2017 Planned initiation date changed from 1 Oct 2017 to 1 Dec 2017.
- 07 Aug 2017 New trial record